Sutton

Posted 1 year ago by Wales Gene Park

Brief Summary The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and efficacy of ponatinib in children aged 1 to < 18 years with advanced leukemias, lymphomas, and solid tumors.

 Chronic Myeloproliferative Disorders /  Sutton

Posted 1 year ago by Wales Gene Park

Brief Summary The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and efficacy of ponatinib in children aged 1 to < 18 years with advanced leukemias, lymphomas, and solid tumors.

 Chronic myeloid leukemia (CML) /  Sutton


No post found